Boehringer Ingelheim Pharmaceuticals, Inc., recently announced the initiation of a trial to compare the safety, tolerability, and pharmacokinetics of adding pirfenidone (Esbriet) to treatment with OFEV (nintedanib, Boehringer Ingelheim) in patients with idiopathic pulmonary fibrosis (IPF). IPF, a type of interstitial lung disease affecting the tissue that supports the…
Idiopathic Pulmonary Fibrosis Trial to Test Combination of Existing Treatments
In a newly published paper in the Stem Cells Translational Medicine journal entitled Adult Lung Spheroid Cells Contain Progenitor Cells and Mediate Regeneration in Rodents With Bleomycin-Induced Pulmonary Fibrosis, scientists from North Carolina State University discovered a quick and simple method to produce stem cells from…
Read the articles: 1. Pulmonary Fibrosis Study Points to Protective Effects of Vitamin D 2. ‘Organs on Chips’ May Revolutionize Lung, Other Disease Research 3. IPF Patients with Chronic Cough Sought for Phase 2 Clinical Trial …
In a new study, researchers reported a novel role for a receptor at the surface of macrophages (specialized cells of the immune system) in lung fibrosis resolution. The study, titled “TRPV4 Mechanosensitive Ion Channel Regulates LPS-Stimulated Macrophage Phagocytosis,” was published in the…
Learn more about IPF: https://bit.ly/1QiRmr3 Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of…
Remember to always enjoy life and keep breathing. Read the most recent news on Pulmonary Fibrosis. Click here: https://bit.ly/1lfMsiZ…
https://www.youtube.com/watch?v=SYssJOKfZ_U Meet Dyane. She shares what she fears most about her pulmonary fibrosis diagnosis and explains how this diagnosis has impacted her life. The thing she hates the most is not being able to be an active grandmother, with her eight grandchildren. Watch the video to hear her story.
Watch the video to learn more about pulmonary diseases, lung functions, COPD, types of emphysema, and its symptoms and diagnosis. Learn more about Pulmonary Fibrosis and Emphysema: https://bit.ly/1ONmRdG…
An analysis of pooled data from three Phase 3 clinical trials in idiopathic pulmonary fibrosis (IPF) patients shows that treatment with pirfenidone for one year significantly reduced disease progression. The study, titled “Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials,” was published in…
A team of researchers from the Department of Clinical and Experimental Medicine at the University of Catania, Italy recently reviewed the co-occurrence of additional diseases in Idiopathic Pulmonary Fibrosis and their current therapeutic strategies. The study, entitled “IPF, comorbidities and management implications,“ was published in the Sarcoidosis Vasculitis…
